Latest News
Tiltbio presents data from fully intravenously treated patients at ESMO Congress 2025
TILT Biotherapeutics Announces Closing of USD 25 Million Series B Financing
Tiltbio presents data related to clinical-immunological corralates in ovarian cancer at AACR
GEN’s article on TILs’ tomorrow
Tiltbio news featured in MedNous January 2025
Upcoming Events
Please contact our business development team to meet us at the following events: